This inventor holds 4 USPTO granted patents. Top assignee: Koronis Pharmaceuticals, Inc.. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Title: Kevin Harris: Innovator in Pharmaceutical Chemistry
Introduction
Kevin Harris is a notable inventor based in Bothell, WA (US), recognized for his contributions to pharmaceutical chemistry. With a total of 4 patents, he has made significant strides in the development of prodrugs aimed at enhancing therapeutic efficacy.
Latest Patents
Among his latest innovations, Harris has developed prodrugs of heteroaryl compounds. These inventions provide hydrophobic prodrugs of bases, nucleosides, and nucleotides, along with methods for utilizing these prodrugs as antiviral and anti-cancer chemotherapeutic agents. His work in this area demonstrates a commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Harris is currently employed at Koronis Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research. His expertise in the field has positioned him as a key player in the development of innovative therapeutic solutions.
Collaborations
Throughout his career, Harris has collaborated with esteemed colleagues, including Richard Daifuku and Alexander A Gall. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kevin Harris stands out as a dedicated inventor in the realm of pharmaceutical chemistry, with a focus on creating effective prodrugs for critical medical applications. His contributions are paving the way for advancements in antiviral and anti-cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile